We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Updates Reexamination Process for Pediatric Trial Plans
EMA Updates Reexamination Process for Pediatric Trial Plans
February 13, 2015
Drugmakers should notify the European Medicines Agency within 10 days of receiving an initial opinion on a pediatric investigation plan if they plan to request another review.